InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Other Non Operating Income (2017 - 2026)

InflaRx (IFRX) posted Other Non Operating Income of $940296.1 for Q1 2026, down 92.29% sequentially from $12.2 million in Q4 2025, and down 85.37% YoY from $6.4 million in Q1 2025.

InflaRx (IFRX) Other Non Operating Income (2017 - 2026) Analysis & Trends

InflaRx has reported Other Non Operating Income for 10 years, with the latest figure at $940296.1 in Q1 2026.

  • Quarterly Other Non Operating Income fell 85.37% year-over-year to $940296.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (down 25.68% YoY) and the FY2025 annual result came in at $6.4 million, up 61.66% from the prior year.
  • Other Non Operating Income slipped to $940296.1 in Q1 2026 per IFRX's latest filing, from $12.2 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $12.2 million in Q4 2025 and troughed at -$1220.7 billion in Q1 2023.
  • A 5-year average of -$71.8 billion and a median of $835908.5 in 2023 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2022 and 2023: Other Non Operating Income surged 267.67% in 2022, then tumbled 149417763.85% in 2023.
  • Over 5 years, Other Non Operating Income stood at -$746398.7 in 2022, then sank by 442.75% to -$4.1 million in 2023, then soared by 205.04% to $4.3 million in 2024, then jumped by 186.79% to $12.2 million in 2025, then slumped by 92.29% to $940296.1 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $940296.1, $12.2 million, and -$3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 940,296.08
Dec 31, 2025 12.20 Mn
Sep 30, 2025 -3.71 Mn
Jun 30, 2025 -3.25 Mn
Mar 31, 2025 6.43 Mn
Dec 31, 2024 4.26 Mn
Sep 30, 2024 -3.13 Mn
Jun 30, 2024 766,109.67
Mar 31, 2024 1.98 Mn
Dec 31, 2023 -4.05 Mn
Sep 30, 2023 2.50 Mn
Jun 30, 2023 835,908.45
Mar 31, 2023 -1,220.72 Bn
Dec 31, 2022 -746,398.69
Sep 30, 2022 889,671.02
Jun 30, 2022 1.67 Mn
Mar 31, 2022 816,986.66
Dec 31, 2021 2,246.91 Bn
Sep 30, 2021 844,132.69
Jun 30, 2021 -995,093.10